These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6134111)

  • 1. Aluminium toxicity in an infant not on dialysis.
    Randall ME
    Lancet; 1983 Jun; 1(8337):1327-8. PubMed ID: 6134111
    [No Abstract]   [Full Text] [Related]  

  • 2. Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy.
    Davenport A; Ahmad R
    Scand J Urol Nephrol; 1988; 22(2):159-60. PubMed ID: 3144735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What treatment would you advise for a 1-year-old child with chronic renal failure who has been on aluminum hydroxide as a phosphate binder for 6 months and then develops epilepsy and is found to have a grossly raised plasma aluminum concentration?
    Andreoli SP; Chesney RW; Salusky IB; Sedman AB
    Pediatr Nephrol; 1990 Jul; 4(4):318. PubMed ID: 2206897
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.
    Graf H
    Intensive Care Med; 1988; 14(4):445-6. PubMed ID: 3403784
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperaluminaemia associated with oral citrate and aluminium hydroxide.
    Kirschbaum BB; Schoolwerth AC
    Hum Toxicol; 1989 Jan; 8(1):45-7. PubMed ID: 2714810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis encephalopathy: recovery after interruption of aluminium intake.
    Poisson M; Mashaly R; Lebkiri B
    Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.
    Mackway-Jones K; Cove-Smith R; Lawler P
    Intensive Care Med; 1987; 13(4):293-4. PubMed ID: 3497185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised plasma aluminium in an infant on antacid.
    Puntis JW; Ballantine NE; Durbin GM
    Lancet; 1989 Oct; 2(8668):923. PubMed ID: 2571845
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F; Monnier N; Reveillaud RJ
    Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of aluminium toxicity in a 'low incidence' area.
    Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
    Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminium in joint tissues of patient taking aluminium hydroxide.
    Netter P; Burnel D; Hutin MF; Kessler MF; Faure G
    Lancet; 1981 May; 1(8228):1056. PubMed ID: 6112436
    [No Abstract]   [Full Text] [Related]  

  • 14. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia.
    O'Donovan R; Baldwin D; Hammer M; Moniz C; Parsons V
    Lancet; 1986 Apr; 1(8486):880-2. PubMed ID: 2870354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminium hydroxide intake: real risk of aluminium toxicity.
    Cannata JB; Briggs JD; Junor BJ; Fell GS
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1937-8. PubMed ID: 6407646
    [No Abstract]   [Full Text] [Related]  

  • 16. 1 alpha OH vitamin D3 increases plasma aluminium in haemodialysed patients taking Al (OH)3.
    Fournier A; Demontis R; Tahiri Y; Herve M; Moriniere P; Leflon A; Abdull-Massih Z; Atik H; Benelmouffok S
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():390-4. PubMed ID: 3991529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral aluminum and neuropsychological functioning. A study of dialysis patients receiving aluminum hydroxide gels.
    Rosati G; De Bastiani P; Gilli P; Paolino E
    J Neurol; 1980; 223(4):251-7. PubMed ID: 6157787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iatrogenic aluminum osteopathy in a uremic infant].
    Koch H; Reich H; Franke D; Delling G
    Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
    Wallace MR; Pybus J
    N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can aluminium-containing antacid produce dementia?
    Jobst K; Nagy J
    Nephron; 1995; 71(4):473. PubMed ID: 8587635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.